Why the study?
Does azimilide safely and effectively treat supraventricular and ventricular arrhythmias?
Does azimilide safely and effectively treat supraventricular and ventricular arrhythmias?
Azimilide demonstrates efficacy in suppressing supraventricular arrhythmias and preventing new-onset atrial fibrillation, but does not improve survival in high-risk post-MI patients.
No takes yet. Share an insight, caveat, or question.
May reduce arrhythmia recurrences post-MI without mortality benefit; leaves open its role versus contemporary agents in prospective trials.
Vernooy et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: